Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (101-110 of 186) with videos related to

Pageof 19
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|August 17, 2020
Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancerJessica S Donington, Rebecca Paulus, Martin J Edelman, et al.
Cancer Investigation|March 20, 2003
Phase I trial of gemcitabine and paclitaxel in advanced solid tumorsNelson Lim, Primo N Lara, Derick H M Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemiasKen Shiozawa, Takeo Nakanishi, Ming Tan, et al.
Journal of Palliative Medicine|September 1, 2025
A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship TrainingJessica R Bauman, Madeline Albert, Marcin Chwistek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelMartin J Edelman, Joseph I Clark, Kari Chansky, et al.
Molecular and Cellular Pharmacology|August 16, 2014
Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic ModulationAdam S Reese, Steven J Feigenberg, Azmat Husain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303)Antonius A Miller, Xiaofei F Wang, Lin Gu, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Clinical Lung Cancer|December 5, 2003
Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancerPaul J Hesketh, Christopher J Nauman, Ann M Hesketh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology GroupShadia Jalal, David Waterhouse, Martin J Edelman, et al.
Pageof 19

Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Thoracic and Cardiovascular Surgery|August 17, 2020
Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancerJessica S Donington, Rebecca Paulus, Martin J Edelman, et al.
Cancer Investigation|March 20, 2003
Phase I trial of gemcitabine and paclitaxel in advanced solid tumorsNelson Lim, Primo N Lara, Derick H M Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemiasKen Shiozawa, Takeo Nakanishi, Ming Tan, et al.
Journal of Palliative Medicine|September 1, 2025
A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship TrainingJessica R Bauman, Madeline Albert, Marcin Chwistek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelMartin J Edelman, Joseph I Clark, Kari Chansky, et al.
Molecular and Cellular Pharmacology|August 16, 2014
Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic ModulationAdam S Reese, Steven J Feigenberg, Azmat Husain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303)Antonius A Miller, Xiaofei F Wang, Lin Gu, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Clinical Lung Cancer|December 5, 2003
Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancerPaul J Hesketh, Christopher J Nauman, Ann M Hesketh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology GroupShadia Jalal, David Waterhouse, Martin J Edelman, et al.
Pageof 19